Community

Mike RicksGeneral

5 months ago

GHK-Cu blends

Just for general information since I see it all over TikTok, blended stacks containing GHK-Cu does NOT result in degradation levels that would render the outcome changed. This test has been done several times, including by Jano with the same results. I’ve posted them here as well.

Mike RicksMuscle Gain

6 months ago

Anti-doping policy is crystal-clear in 2026: peptide hormones & growth factors are squarely prohibited.

WADA’s 2026 Prohibited List (in force Jan 1, 2026) keeps “Peptide hormones, growth factors, related substances and mimetics” as a core prohibited category—this is the umbrella that catches many performance peptides and peptide-like agents used for physique enhancement. USADA continues to publish enforcement messaging around these peptides (including that several popular injectable peptides are not FDA-approved and can pose significant health risks for athletes). https://www.wada-ama.org/en/news/wadas-2026-prohibited-list-now-force?utm_source=chatgpt.com https://www.usada.org/sanction/anthony-mccauley-accepts-doping-sanction/?utm_source=chatgpt.com

Mike RicksMuscle Gain

6 months ago

FDA’s compounding stance keeps key “bodybuilding peptides” in the crosshairs.

FDA’s “significant safety risks” compounding page explicitly lists ipamorelin acetate and GHRP-6, flagging concerns like immunogenicity/aggregation/peptide impurities, and for CJC-1295 notes serious adverse events reported (e.g., increased heart rate/systemic vasodilatory reaction) and limited clinical data. FDA materials also show CJC-1295-related substances were actively evaluated through the Pharmacy Compounding Advisory Committee process (a signal the agency treats these as non-trivial safety/regulatory questions). https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks?utm_source=chatgpt.com https://www.fda.gov/media/183819/download?utm_source=chatgpt.com

Mike RicksMuscle Gain

6 months ago

The “research peptide” bodybuilding market is getting more scrutiny (late 2025 → Feb 2026).

Multiple recent investigations describe a surge in unapproved injectable peptides promoted for muscle gain/recovery (commonly discussed in bodybuilding circles: BPC-157, TB-500/thymosin-β4–related products, growth-hormone secretagogues like ipamorelin/CJC-1295), and stress that products are often unregulated powders/vials with purity/contamination/dosing concerns. A legal/regulatory brief notes FDA warning letters have targeted online peptide marketing even when sellers claim “research use only,” when the marketing suggests human use (e.g., physique/performance claims). https://www.frierlevitt.com/articles/injectable-peptides-fda-state-enforcement-compounding/?utm_source=chatgpt.com

Mike RicksCognitive

6 months ago

Consumer “nootropic peptides” (Semax/Selank) are trending hard!!

Mainstream coverage (Jan 2026) highlights rising use of intranasal “nootropic peptides” like Selank and Semax, often framed as enhancing cognition/brain fog or mood. The FDA’s compounding/bulk-substances safety-risk list explicitly includes Semax (heptapeptide) and Selank acetate, citing concerns like immunogenicity/aggregation/peptide impurities and limited safety information for certain routes of administration—this is one of the most direct, official signals shaping the U.S. peptide marketplace right now. Broader reporting on the grey-market injectable peptide craze reinforces the regulatory/safety theme (unregulated sourcing, adverse event risk), which is directly relevant to cognitive-peptide demand. https://www.vogue.com/article/nasal-peptides https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks?utm_source=chatgpt.com https://www.theguardian.com/wellness/2026/feb/05/injectable-peptides-trend

Mike RicksHealing

6 months ago

Major recent coverage describes a fast-growing U.S. trend of people injecting unapproved peptides marketed for faster injury recovery / healing (commonly BPC-157 and TB-500 / thymosin-β4–related), often sourced online and sold as “research use only,” with experts warning about lack of robust human evidence, quality/purity risks, and unpredictable side effects. AP reporting similarly highlights how “healing” claims (injury recovery, tissue repair) are a major driver of peptide adoption, while emphasizing the regulatory gray zone and limited clinical support for many of the most-hyped compounds. https://www.theguardian.com/wellness/2026/feb/05/injectable-peptides-trend?utm_source=chatgpt.com https://apnews.com/article/peptide-injections-rfk-maha-4d48e78a5d65658b4d6eac87818352e3

Mike RicksAnti-Aging

6 months ago

New academic publications continue to explore “longevity-linked” peptides (e.g., mitochondrial-derived peptides like MOTS-c) in metabolic contexts, but these are research findings, not proof of anti-aging benefit in humans. https://www.nature.com/articles/s41598-026-39687-x?utm_source=chatgpt.com

Mike RicksAnti-Aging

6 months ago

Reporting on “special jurisdiction” trials (e.g., Próspera, Honduras) describes companies pursuing gene-therapy–style longevity regimens that include follistatin (a protein that modulates growth pathways) as part of an anti-aging narrative, with timelines for early readouts discussed publicly. https://pharma.nridigital.com/pharma_jan26/in-a-honduran-city-biotechs-create-gene-therapy-cocktails-to-fight-ageing?utm_source=chatgpt.com

Mike RicksFat Loss

6 months ago

Viking Therapeutics’ VK2735 (GLP-1/GIP dual agonist) advanced toward late-stage development, with Reuters reporting plans to move its oral formulation into late-stage testing later in 2026—signaling continued momentum for dual-agonist peptides and more convenient dosing/maintenance strategies. https://www.reuters.com/business/healthcare-pharmaceuticals/viking-therapeutics-plans-advance-oral-obesity-drug-late-stage-trial-2026-02-11/?utm_source=chatgpt.com

Mike RicksFat Loss

6 months ago

CagriSema (semaglutide + cagrilintide; GLP-1 + amylin approach) disappointed markets, with reports highlighting ~23% average weight loss over 84 weeks and framing it as less competitive vs Lilly’s tirzepatide benchmarks—driving a sharp selloff and a broader “next-gen” narrative shift toward other mechanisms/combos. https://www.theguardian.com/business/2026/feb/23/wegovy-ozempic-weight-loss-drug-novo-nordisk-cagrisema?utm_source=chatgpt.com

Mike RicksFat Loss

6 months ago

Novo Nordisk’s “triple G” obesity candidate UBT251 (GLP-1/GIP/glucagon agonist) posted strong mid-stage data in China: up to ~19.7% mean weight loss at 24 weeks (highest dose) vs ~2% for placebo. Novo has also initiated a global Phase 2 program (ex-Greater China) following a 2025 licensing deal. https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-united-biotechnology-obesity-drug-trial-shows-197-weight-loss-2026-02-24/?utm_source=chatgpt.com

Mike RicksGeneral

6 months ago

Just a quick note to say thanks for being among the first to join the page and community! If you like what you see and find the tools and information useful, please spread the word. Also, the Prism Aminos team will be adding more common stacks to the list and expanding the Resources library with additional protocols daily.

Mike RicksResults

6 months ago

Welcome!!

Welcome to Results! 🎯 Share your transformation photos, metrics, and success stories. Celebrate wins (big and small), ask questions about others' results, and get inspired by community members' progress.

Mike RicksProtocols

6 months ago

Welcome!!

Welcome to Protocols! 📋 This is your hub for sharing and discussing detailed peptide protocols, dosing guides, reconstitution methods, and reconstitution calculators. Ask questions and refine your protocols here.

Mike RicksCognitive

6 months ago

Welcome!!

Welcome to Cognitive Enhancement! 🧠 Discuss nootropic peptides, brain health, focus, and mental performance. Share strategies for optimizing cognition and learn from community experiences.

Mike RicksHealing

6 months ago

Welcome!!

Welcome to Healing & Recovery! 🩹 This channel is for peptides and protocols focused on injury recovery, joint health, and tissue repair (BPC-157, TB-500, etc.). Share your recovery journey and support others.

Mike RicksAnti-Aging

6 months ago

Welcome!!

Welcome to the Anti-Aging channel! ⏰ Explore peptides for longevity, cellular health, and rejuvenation. Discuss research, share experiences, and discover strategies to optimize your healthspan.

Mike RicksMuscle Gain

6 months ago

Welcome!!

Welcome to Muscle Gain! 💪 Here we discuss peptides and protocols for lean muscle development (HGH secretagogues, IGF-1, etc.). Share your cycles, ask for guidance, and celebrate wins with the community.

Mike RicksFat Loss

6 months ago

Welcome!!

Welcome to the Fat Loss channel! 🔥 Share your goals, discuss effective peptides and stacks for fat loss (GLP-1, CJC-1295, etc.), post progress updates, and learn from others' experiences. Let's support each other on this journey.

Mike RicksGeneral

6 months ago

Welcome!!

Welcome to Prism Aminos Community! 🧬 This is your space to connect with fellow members, introduce yourself, ask questions, and discuss peptides, protocols, and optimization strategies. Let's build something amazing together.